Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells

Yuhan Chen, Ching‐Chieh Su, Wu Deng, Leslie F. Lock, Peter J. Donovan, Matthew A. Kayala, Pierre Baldi, Hsiao-Chen Lee, Yumay Chen, Ping H. WangScientific 2019 · DOI

TL;DR

This study reveals a novel role for mitochondrial Akt1 signaling in enhancing the efficiency of somatic cell reprogramming into induced pluripotent stem cells (iPSCs). By targeting Akt1 specifically to mitochondria, researchers demonstrated a significant boost in reprogramming success, leading to iPSCs with pluripotency markers and the ability to differentiate into all three germ layers.

What Problem Does This Paper Address?

The process of reprogramming somatic cells back into a pluripotent state, akin to embryonic stem cells (ESCs), is a cornerstone of regenerative medicine. However, the intricate signaling pathways that govern this transformation are not fully understood, leading to inefficiencies and challenges in controlling the process. While the role of the Akt signaling pathway in general cellular processes like proliferation and survival is well-established, its specific contribution to mitochondrial function and its impact on somatic cell reprogramming remained unclear. This paper aims to elucidate the role of mitochondrial Akt1 signaling in this crucial biological process.

Methods

The researchers employed a sophisticated approach to specifically target and manipulate mitochondrial Akt1 signaling. They engineered adenoviral vectors to express either a constitutively active form of Akt1 (Mito-Akt1) or a dominant-negative form (Mito-dnAkt1), both equipped with a mitochondria-targeting sequence. This ensured that the manipulation of Akt1 primarily occurred within the mitochondria, minimizing interference with its cytoplasmic functions.

Key techniques included:

  • Viral Transduction: Introducing the engineered adenoviral vectors into mouse embryonic fibroblasts (MEFs) and human dermal fibroblasts.
  • Reprogramming: Utilizing the established four-factor (Oct4, Sox2, Klf4, c-Myc) method to induce pluripotency.
  • Pluripotency Assays: Assessing reprogramming efficiency through alkaline phosphatase (AP) staining and expression of stem cell markers like SSEA-1, Oct4, Sox2, and Nanog.
  • In Vitro and In Vivo Differentiation: Evaluating the pluripotency of generated iPSCs by inducing embryoid body formation and performing teratoma formation assays in immunocompromised mice.
  • Epigenetic Analysis: Investigating the methylation status of Oct4 and Nanog promoters using bisulfite sequencing.
  • Mitochondrial Function Assays: Employing Seahorse XF24 analyzers to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to assess cellular respiration and glycolysis.
  • Western Blotting: Analyzing protein expression and phosphorylation levels of Akt and other relevant markers.
  • Confocal Microscopy: Visualizing the subcellular localization of phosphorylated Akt.
  • Gene Expression Profiling: Using Affymetrix DNA microarrays to analyze global gene expression changes in human ESCs.

Datasets

The study utilized primary cell cultures:

  • Mouse Embryonic Fibroblasts (MEFs): Used for initial reprogramming experiments.
  • Human Dermal Fibroblasts: Used to confirm the effect of mitochondrial Akt1 signaling on human somatic cell reprogramming.
  • Mouse Embryonic Stem Cells (mESCs): Used as a benchmark for pluripotency and metabolic profiles.
  • Human Embryonic Stem Cell (hESC) line H9: Used for investigating the effect of mitochondrial Akt1 on stemness and gene expression.

No new public datasets were introduced or used for benchmarking in this study.

Key Insights and Ideas

  • Mitochondrial Akt1 is a key regulator of reprogramming efficiency: The most striking finding is that specifically targeting Akt1 to mitochondria significantly enhances the efficiency of somatic cell reprogramming. This suggests that mitochondria play a more direct and active role in this process than previously appreciated.
  • Mitochondrial Akt1 influences epigenetic reprogramming: The study observed reduced methylation of Oct4 and Nanog promoters in iPSCs generated with Mito-Akt1. This indicates that mitochondrial Akt1 signaling can impact the epigenetic landscape, which is crucial for silencing somatic cell identity and activating pluripotency genes.
  • Mitochondrial Akt1 modulates cellular bioenergetics to resemble ESCs: The iPSCs generated with enhanced mitochondrial Akt1 signaling exhibited a metabolic profile (OCR and ECAR) similar to ESCs, differing from the parental fibroblasts. This suggests that mitochondrial Akt1 helps steer the metabolic state towards that of pluripotent cells.
  • Mitochondrial Akt1 signaling is required, not just beneficial: The use of a dominant-negative form of mitochondrial Akt1 (Mito-dnAkt1) demonstrated that inhibiting this pathway significantly impaired reprogramming, highlighting its essential role.
  • Akt1's mitochondrial localization is crucial: The study emphasizes that the effects observed are due to Akt1's action within the mitochondria, distinct from its known cytoplasmic roles. This opens up new avenues for understanding Akt signaling in a compartmentalized manner.

Key Results

  • Enhanced Reprogramming Efficiency: Transduction with Mito-Akt1 led to a significant increase in the number of alkaline phosphatase-positive colonies in both mouse and human fibroblasts.
  • Pluripotency Confirmed: The resulting iPSCs expressed key pluripotency markers (Oct4, Sox2, Nanog, SSEA-1) and were capable of forming embryoid bodies in vitro and teratomas in vivo, differentiating into all three germ layers.
  • Reduced Promoter Methylation: iPSCs generated with Mito-Akt1 showed significantly less methylation in the Oct4 and Nanog promoter regions compared to those generated without it.
  • Metabolic Shift: iPSCs with enhanced mitochondrial Akt1 signaling displayed an oxygen consumption rate (OCR) similar to ESCs, while control iPSCs had an OCR more akin to fibroblasts. Glycolysis (ECAR) was comparable across iPSC groups and similar to ESCs.
  • Gene Expression Changes in hESCs: In human ESCs, Mito-Akt1 expression led to the upregulation of genes promoting stem cell self-renewal and survival, and downregulation of genes associated with differentiation.

Limitations and Future Work

  • Cell-type Specificity: While the study demonstrated effects in fibroblasts and ESCs, further investigation into other somatic cell types would be beneficial.
  • Mechanism of Action: While the study shows that mitochondrial Akt1 is important, the precise molecular mechanisms by which it influences reprogramming, epigenetic modifications, and metabolic shifts require deeper exploration.
  • Translational Potential: The study provides a strong foundation for exploring therapeutic strategies that target mitochondrial Akt1 for improved cell reprogramming and regenerative medicine applications. Future work could focus on developing small molecules or other interventions to modulate mitochondrial Akt1 activity.
  • ROS Modulation: The paper hints at mitochondrial Akt1's role in reducing oxidative stress in MEFs under stress conditions. Further research could explore this protective role in the context of reprogramming.

Summary updated

Abstract

The signaling mechanisms controlling somatic cell reprogramming are not fully understood. In this study, we report a novel role for mitochondrial Akt1 signaling that enhanced somatic cell reprogramming efficiency. The role of mitochondrial Akt1 in somatic cell reprogramming was investigated by transducing fibroblasts with the four reprogramming factors (Oct4, Sox2, Klf4, c-Myc) in conjunction with Mito-Akt1, Mito-dnAkt1, or control virus. Mito-Akt1 enhanced reprogramming efficiency whereas Mito-dnAkt1 inhibited reprogramming. The resulting iPSCs formed embryoid bodies in vitro and teratomas in vivo. Moreover, Oct4 and Nanog promoter methylation was reduced in the iPSCs generated in the presence of Mito-Akt1. Akt1 was activated and translocated into mitochondria after growth factor stimulation in embryonic stem cells (ESCs). To study the effect of mitochondrial Akt in ESCs, a mitochondria-targeting constitutively active Akt1 (Mito-Akt1) was expressed in ESCs. Gene expression profiling showed upregulation of genes that promote stem cell proliferation and survival and down-regulation of genes that promote differentiation. Analysis of cellular respiration indicated similar metabolic profile in the resulting iPSCs and ESCs, suggesting comparable bioenergetics. These findings showed that activation of mitochondrial Akt1 signaling was required during somatic cell reprogramming.
BibTeX
@inproceedings{chen2019mitochondrial,
  author = {Yuhan Chen and Ching‐Chieh Su and Wu Deng and Leslie F. Lock and Peter J. Donovan and Matthew A. Kayala and Pierre Baldi and Hsiao-Chen Lee and Yumay Chen and Ping H. Wang},
  title = {{Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-46359-6},
}
Figure